Raymond James Trust N.A. trimmed its holdings in Quintiles Transitional Holdings Inc. (NYSE:Q) by 16.4% during the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 2,437 shares of the medical research company’s stock after selling 477 shares during the quarter. Raymond James Trust N.A.’s holdings in Quintiles Transitional Holdings were worth $218,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also modified their holdings of the company. Vanguard Group Inc. raised its holdings in shares of Quintiles Transitional Holdings by 0.9% in the first quarter. Vanguard Group Inc. now owns 12,508,830 shares of the medical research company’s stock worth $1,007,336,000 after buying an additional 113,613 shares during the period. Longview Partners Guernsey LTD raised its holdings in shares of Quintiles Transitional Holdings by 6.2% in the second quarter. Longview Partners Guernsey LTD now owns 8,711,447 shares of the medical research company’s stock worth $779,675,000 after buying an additional 505,526 shares during the period. Janus Capital Management LLC raised its holdings in shares of Quintiles Transitional Holdings by 0.4% in the first quarter. Janus Capital Management LLC now owns 7,783,546 shares of the medical research company’s stock worth $626,804,000 after buying an additional 27,675 shares during the period. BlackRock Inc. raised its holdings in shares of Quintiles Transitional Holdings by 4,217.1% in the first quarter. BlackRock Inc. now owns 7,098,723 shares of the medical research company’s stock worth $571,660,000 after buying an additional 6,934,290 shares during the period. Finally, State Street Corp raised its holdings in shares of Quintiles Transitional Holdings by 2.6% in the first quarter. State Street Corp now owns 2,847,886 shares of the medical research company’s stock worth $229,337,000 after buying an additional 71,563 shares during the period. Hedge funds and other institutional investors own 91.34% of the company’s stock.

Several brokerages have recently weighed in on Q. Barclays PLC reiterated an “overweight” rating and issued a $98.00 price target (up from $90.00) on shares of Quintiles Transitional Holdings in a report on Monday, July 17th. William Blair upgraded Quintiles Transitional Holdings from a “market perform” rating to an “outperform” rating and raised their price objective for the stock from $70.10 to $93.42 in a report on Friday, August 4th. Jefferies Group LLC restated a “hold” rating and set a $94.00 price objective on shares of Quintiles Transitional Holdings in a report on Friday, August 4th. Citigroup Inc. raised their price objective on Quintiles Transitional Holdings from $96.00 to $97.00 and gave the stock a “neutral” rating in a report on Monday, August 7th. Finally, Royal Bank Of Canada began coverage on Quintiles Transitional Holdings in a report on Tuesday. They set an “outperform” rating and a $116.00 price objective on the stock. Eleven analysts have rated the stock with a hold rating, ten have issued a buy rating and one has issued a strong buy rating to the company. Quintiles Transitional Holdings currently has a consensus rating of “Buy” and a consensus price target of $92.44.

Shares of Quintiles Transitional Holdings Inc. (Q) opened at 94.22 on Friday. Quintiles Transitional Holdings Inc. has a 12 month low of $70.10 and a 12 month high of $99.95. The firm’s 50-day moving average price is $93.80 and its 200 day moving average price is $86.86. The company has a market cap of $20.40 billion, a PE ratio of 273.10 and a beta of 0.63.

Quintiles Transitional Holdings (NYSE:Q) last posted its quarterly earnings data on Thursday, August 3rd. The medical research company reported $1.09 earnings per share for the quarter, topping analysts’ consensus estimates of $1.05 by $0.04. Quintiles Transitional Holdings had a return on equity of 14.23% and a net margin of 0.82%. The business had revenue of $1.97 billion for the quarter, compared to analyst estimates of $1.96 billion. During the same quarter in the prior year, the company earned $0.93 earnings per share. The company’s revenue was up 68.7% on a year-over-year basis. Equities research analysts anticipate that Quintiles Transitional Holdings Inc. will post $4.58 earnings per share for the current fiscal year.

In other news, major shareholder Cpp Investment Board Private H sold 6,748,026 shares of the company’s stock in a transaction on Tuesday, September 19th. The stock was sold at an average price of $94.87, for a total transaction of $640,185,226.62. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Also, Director John Connaughton sold 1,030,429 shares of the company’s stock in a transaction on Tuesday, September 19th. The stock was sold at an average price of $94.87, for a total value of $97,756,799.23. The disclosure for this sale can be found here. Insiders have sold 14,142,302 shares of company stock worth $1,356,515,722 in the last ninety days. Corporate insiders own 6.40% of the company’s stock.

TRADEMARK VIOLATION WARNING: This piece was originally published by Daily Political and is owned by of Daily Political. If you are viewing this piece on another site, it was illegally copied and republished in violation of US & international copyright law. The legal version of this piece can be read at https://www.dailypolitical.com/2017/09/22/quintiles-transitional-holdings-inc-q-stake-decreased-by-raymond-james-trust-n-a.html.

About Quintiles Transitional Holdings

Quintiles IMS Holdings, Inc, formerly Quintiles Transnational Holdings Inc, provides integrated information and technology-enabled healthcare services. The Company operates through segments, including Commercial Solutions; Research & Development Solutions, and Integrated Engagement Services. The Commercial Solutions segment offerings include national information offerings, sub-national information offerings, technology solutions, and workflow analytics and consulting services.

Institutional Ownership by Quarter for Quintiles Transitional Holdings (NYSE:Q)

Receive News & Ratings for Quintiles Transitional Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quintiles Transitional Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.